Osteoprotegerin in breast cancer: beyond bone remodeling.
Osteoprotegerin in breast cancer: beyond bone remodeling.
复制标题
DOI：
10.1186/s12943-015-0390-5
复制
发表时间：
2015-06-10
期刊：
影响因子：
37.3
通讯作者：
Connelly L
中科院分区：
文献类型：
--
作者：
Weichhaus M;Chung ST;Connelly L
Osteoprotegerin (OPG) is a secreted protein and member of the Tumor Necrosis Factor (TNF) Receptor superfamily. OPG has been well characterized as a regulator of bone metabolism which acts by blocking osteoclast maturation and preventing bone breakdown. Given this role, early studies on OPG in breast cancer focused on the administration of OPG in order to prevent the osteolysis observed with bone metastases. However OPG is also produced by the breast tumor cells themselves. Research focusing on OPG produced by breast tumor cells has revealed actions of OPG which promote tumor progression. In vitro studies into the role of OPG produced by breast tumor cells have demonstrated that OPG can block TNF-related apoptosis inducing ligand (TRAIL)-mediated apoptosis. Furthermore, in vivo studies show that OPG expression by breast tumors can promote tumor growth and metastasis. In addition it has been shown that OPG stimulates endothelial cell survival and tube formation thus it may indirectly promote breast tumor progression through impacting angiogenesis. This article will present a summary of the data concerning the tumor-promoting effects of OPG in breast cancer.
登录
查看更多内容
影响因子：
4
作者：
Rachner, Tilman D.;Benad, Peggy;Hofbauer, Lorenz C.
通讯作者：
Hofbauer, Lorenz C.
影响因子：
6.4
作者：
Cross, SS;Yang, ZY;Holen, I
通讯作者：
Holen, I
影响因子：
2.5
作者：
Park, Hyung Seok;Lee, Ahwon;Jung, Sang Seol
通讯作者：
Jung, Sang Seol
影响因子：
9.8
作者：
Benslimane-Ahmim, Zahia;Poirier, Florence;Boisson-Vidal, Catherine
通讯作者：
Boisson-Vidal, Catherine
影响因子：
6.4
作者：
Ottewell, Penelope D.;Wang, Ning;Holen, Ingunn
通讯作者：
Holen, Ingunn